APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis

Masahiro Yokouchi, Toru Wakioka, Hiroshi Sakamoto, Hideo Yasukawa, Satoshi Ohtsuka, Atsuo Sasaki, Motoaki Ohtsubo, Mindaugas Valius, Akio Inoue, Setsuro Komiya, Akihiko Yoshimura

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Previously we cloned a novel adaptor protein, APS (adaptor molecules containing PH and SH2 domains) which was tyrosine phosphorylated in response to c-kit or B cell receptor stimulation. Here we report that APS was expressed in some human osteosarcoma cell lines, markedly so in SaOS-2 cells, and was tyrosine-phosphorylated in response to several growth factors, including platelet derived growth factor (PDGF), insulin-like growth factor (IGF), and granulocyte-macrophage colony stimulating factor (GM-CSF). Ectopic expression of the wild type APS, but not C-terminal truncated APS, in NIH3T3 fibroblasts suppressed PDGF-induced MAP kinase (Erk2) activation, c-fos and c-myc induction as well as cell proliferation. In vitro binding experiments suggest that APS bound to the β type PDGF receptor, mainly via phosphotyrosine 1021 (pY1021). Indeed, tyrosine phosphorylation of PLC-γ, which has been demonstrated to bind to pY1021, but not that of PI3 kinase and associated proteins, was reduced in APS transformants. PDGF induced phosphorylation of the tyrosine residue of APS close to the C-terminal end. In vitro and in vivo binding experiments indicate that the tyrosine phosphorylated C-terminal region of APS bound to c-Cbl, which has been shown to be a negative regulator of tyrosine kinases. Since coexpression of c-Cbl with wild type APS, but not C-terminal truncated APS, synergistically inhibited PDGF-induced c-fos promoter activation, c-Cbl could be a mechanism of inhibitory action of APS on PDGF receptor signaling.

Original languageEnglish
Pages (from-to)759-767
Number of pages9
JournalOncogene
Volume18
Issue number3
DOIs
Publication statusPublished - 1999 Jan 21
Externally publishedYes

Fingerprint

Platelet-Derived Growth Factor Receptors
src Homology Domains
Platelet-Derived Growth Factor
Tyrosine
Phosphotyrosine
Proteins
Phosphorylation
Somatomedins
Osteosarcoma
Granulocyte-Macrophage Colony-Stimulating Factor
Phosphatidylinositol 3-Kinases
Protein-Tyrosine Kinases
Intercellular Signaling Peptides and Proteins
B-Lymphocytes
Phosphotransferases
Fibroblasts
Cell Proliferation
Pleckstrin Homology Domains
Cell Line

Keywords

  • Adaptor molecules containing PH and SH2 domains (APS)
  • Molecular biology
  • Platelet derived growth factor receptor (PDGFR)
  • Signal transduction

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis. / Yokouchi, Masahiro; Wakioka, Toru; Sakamoto, Hiroshi; Yasukawa, Hideo; Ohtsuka, Satoshi; Sasaki, Atsuo; Ohtsubo, Motoaki; Valius, Mindaugas; Inoue, Akio; Komiya, Setsuro; Yoshimura, Akihiko.

In: Oncogene, Vol. 18, No. 3, 21.01.1999, p. 759-767.

Research output: Contribution to journalArticle

Yokouchi, M, Wakioka, T, Sakamoto, H, Yasukawa, H, Ohtsuka, S, Sasaki, A, Ohtsubo, M, Valius, M, Inoue, A, Komiya, S & Yoshimura, A 1999, 'APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis', Oncogene, vol. 18, no. 3, pp. 759-767. https://doi.org/10.1038/sj.onc.1202326
Yokouchi, Masahiro ; Wakioka, Toru ; Sakamoto, Hiroshi ; Yasukawa, Hideo ; Ohtsuka, Satoshi ; Sasaki, Atsuo ; Ohtsubo, Motoaki ; Valius, Mindaugas ; Inoue, Akio ; Komiya, Setsuro ; Yoshimura, Akihiko. / APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis. In: Oncogene. 1999 ; Vol. 18, No. 3. pp. 759-767.
@article{9c02444ab08146389e0381fcb94d11ab,
title = "APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis",
abstract = "Previously we cloned a novel adaptor protein, APS (adaptor molecules containing PH and SH2 domains) which was tyrosine phosphorylated in response to c-kit or B cell receptor stimulation. Here we report that APS was expressed in some human osteosarcoma cell lines, markedly so in SaOS-2 cells, and was tyrosine-phosphorylated in response to several growth factors, including platelet derived growth factor (PDGF), insulin-like growth factor (IGF), and granulocyte-macrophage colony stimulating factor (GM-CSF). Ectopic expression of the wild type APS, but not C-terminal truncated APS, in NIH3T3 fibroblasts suppressed PDGF-induced MAP kinase (Erk2) activation, c-fos and c-myc induction as well as cell proliferation. In vitro binding experiments suggest that APS bound to the β type PDGF receptor, mainly via phosphotyrosine 1021 (pY1021). Indeed, tyrosine phosphorylation of PLC-γ, which has been demonstrated to bind to pY1021, but not that of PI3 kinase and associated proteins, was reduced in APS transformants. PDGF induced phosphorylation of the tyrosine residue of APS close to the C-terminal end. In vitro and in vivo binding experiments indicate that the tyrosine phosphorylated C-terminal region of APS bound to c-Cbl, which has been shown to be a negative regulator of tyrosine kinases. Since coexpression of c-Cbl with wild type APS, but not C-terminal truncated APS, synergistically inhibited PDGF-induced c-fos promoter activation, c-Cbl could be a mechanism of inhibitory action of APS on PDGF receptor signaling.",
keywords = "Adaptor molecules containing PH and SH2 domains (APS), Molecular biology, Platelet derived growth factor receptor (PDGFR), Signal transduction",
author = "Masahiro Yokouchi and Toru Wakioka and Hiroshi Sakamoto and Hideo Yasukawa and Satoshi Ohtsuka and Atsuo Sasaki and Motoaki Ohtsubo and Mindaugas Valius and Akio Inoue and Setsuro Komiya and Akihiko Yoshimura",
year = "1999",
month = "1",
day = "21",
doi = "10.1038/sj.onc.1202326",
language = "English",
volume = "18",
pages = "759--767",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis

AU - Yokouchi, Masahiro

AU - Wakioka, Toru

AU - Sakamoto, Hiroshi

AU - Yasukawa, Hideo

AU - Ohtsuka, Satoshi

AU - Sasaki, Atsuo

AU - Ohtsubo, Motoaki

AU - Valius, Mindaugas

AU - Inoue, Akio

AU - Komiya, Setsuro

AU - Yoshimura, Akihiko

PY - 1999/1/21

Y1 - 1999/1/21

N2 - Previously we cloned a novel adaptor protein, APS (adaptor molecules containing PH and SH2 domains) which was tyrosine phosphorylated in response to c-kit or B cell receptor stimulation. Here we report that APS was expressed in some human osteosarcoma cell lines, markedly so in SaOS-2 cells, and was tyrosine-phosphorylated in response to several growth factors, including platelet derived growth factor (PDGF), insulin-like growth factor (IGF), and granulocyte-macrophage colony stimulating factor (GM-CSF). Ectopic expression of the wild type APS, but not C-terminal truncated APS, in NIH3T3 fibroblasts suppressed PDGF-induced MAP kinase (Erk2) activation, c-fos and c-myc induction as well as cell proliferation. In vitro binding experiments suggest that APS bound to the β type PDGF receptor, mainly via phosphotyrosine 1021 (pY1021). Indeed, tyrosine phosphorylation of PLC-γ, which has been demonstrated to bind to pY1021, but not that of PI3 kinase and associated proteins, was reduced in APS transformants. PDGF induced phosphorylation of the tyrosine residue of APS close to the C-terminal end. In vitro and in vivo binding experiments indicate that the tyrosine phosphorylated C-terminal region of APS bound to c-Cbl, which has been shown to be a negative regulator of tyrosine kinases. Since coexpression of c-Cbl with wild type APS, but not C-terminal truncated APS, synergistically inhibited PDGF-induced c-fos promoter activation, c-Cbl could be a mechanism of inhibitory action of APS on PDGF receptor signaling.

AB - Previously we cloned a novel adaptor protein, APS (adaptor molecules containing PH and SH2 domains) which was tyrosine phosphorylated in response to c-kit or B cell receptor stimulation. Here we report that APS was expressed in some human osteosarcoma cell lines, markedly so in SaOS-2 cells, and was tyrosine-phosphorylated in response to several growth factors, including platelet derived growth factor (PDGF), insulin-like growth factor (IGF), and granulocyte-macrophage colony stimulating factor (GM-CSF). Ectopic expression of the wild type APS, but not C-terminal truncated APS, in NIH3T3 fibroblasts suppressed PDGF-induced MAP kinase (Erk2) activation, c-fos and c-myc induction as well as cell proliferation. In vitro binding experiments suggest that APS bound to the β type PDGF receptor, mainly via phosphotyrosine 1021 (pY1021). Indeed, tyrosine phosphorylation of PLC-γ, which has been demonstrated to bind to pY1021, but not that of PI3 kinase and associated proteins, was reduced in APS transformants. PDGF induced phosphorylation of the tyrosine residue of APS close to the C-terminal end. In vitro and in vivo binding experiments indicate that the tyrosine phosphorylated C-terminal region of APS bound to c-Cbl, which has been shown to be a negative regulator of tyrosine kinases. Since coexpression of c-Cbl with wild type APS, but not C-terminal truncated APS, synergistically inhibited PDGF-induced c-fos promoter activation, c-Cbl could be a mechanism of inhibitory action of APS on PDGF receptor signaling.

KW - Adaptor molecules containing PH and SH2 domains (APS)

KW - Molecular biology

KW - Platelet derived growth factor receptor (PDGFR)

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=0033590606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033590606&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1202326

DO - 10.1038/sj.onc.1202326

M3 - Article

VL - 18

SP - 759

EP - 767

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 3

ER -